Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.

O'Reardon JP, Chopra MP, Bergan A, Gallop R, DeRubeis RJ, Crits-Christoph P.

Biol Psychiatry. 2004 May 1;55(9):957-9.

PMID:
15110741
2.
3.

Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.

Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.

J Clin Psychiatry. 2004 Feb;65(2):238-43.

PMID:
15003079
4.

Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM.

J Psychiatry Neurosci. 2000 Sep;25(4):337-46. Erratum in: J Psychiatry Neurosci. 2000 Nov;25(5):439.

5.
6.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

7.
8.

Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.

Haynes PL, McQuaid JR, Kelsoe J, Rapaport M, Gillin JC.

J Affect Disord. 2004 Dec;83(2-3):253-62.

PMID:
15555723
9.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
10.

Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects.

Porter RJ, Phipps AJ, Gallagher P, Scott A, Stevenson PS, O'Brien JT.

Am J Geriatr Psychiatry. 2005 Jul;13(7):607-15.

PMID:
16009737
11.

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.

Neuropsychobiology. 2007;56(2-3):73-85. Epub 2007 Nov 23.

PMID:
18037817
12.

Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study.

Praschak-Rieder N, Hussey D, Wilson AA, Carella A, Lee M, Dunn E, Willeit M, Bagby RM, Houle S, Meyer JH.

Biol Psychiatry. 2004 Oct 15;56(8):587-91.

PMID:
15476688
13.

Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.

Salminen JK, Karlsson H, Hietala J, Kajander J, Aalto S, Markkula J, Rasi-Hakala H, Toikka T.

Psychother Psychosom. 2008;77(6):351-7. doi: 10.1159/000151388. Epub 2008 Aug 14.

PMID:
18701831
14.

Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.

Argyropoulos SV, Hood SD, Adrover M, Bell CJ, Rich AS, Nash JR, Rich NC, Witchel HJ, Nutt DJ.

Biol Psychiatry. 2004 Oct 1;56(7):503-9.

PMID:
15450786
15.

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.

Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS.

Biol Psychiatry. 1999 Jul 15;46(2):212-20.

PMID:
10418696
16.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
17.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
18.

Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors.

Moore P, Gillin C, Bhatti T, DeModena A, Seifritz E, Clark C, Stahl S, Rapaport M, Kelsoe J.

Arch Gen Psychiatry. 1998 Jun;55(6):534-9.

PMID:
9633672
19.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
20.

Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.

Hood SD, Hince DA, Davies SJ, Argyropoulos S, Robinson H, Potokar J, Nutt DJ.

Psychopharmacology (Berl). 2010 Feb;208(2):223-32. doi: 10.1007/s00213-009-1722-1. Epub 2009 Nov 21.

PMID:
19936713
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk